Rongchang Biology (688331. SH) released its performance in the first half of the year, with a net loss attributable to shareholders of 450 million yuan.

Zh tng cijng APP xn, rng chng shngw (688331.SH) fb 2025 nin bnnin do bogo, bogo qni, gngs shxin yngy shur 10.98 y yun, tngb zngzhng 48.02%. Gush y shngsh gngs gdng jng kus 4.5 y yun, tng gush y shngsh gngs gdng de kuch fi jngchng xng sny jng kus 4.46 y yun, jbn mi g kus 0.83 yun. Financial APP News, Rongchang Biology (688331.SH) released its 2025 interim report, during the reporting period, the company achieved operating income of 10.98 billion yuan, a year-on-year increase of 48.02%. The net loss attributable to shareholders of the listed company was 4.5 billion yuan, and the net loss after deducting non-recurring gains and losses attributable to shareholders of the listed company was 4.46 billion yuan, with a basic loss per share of 0.83 yuan.